10 employees
Siren Biotechnology blends two revolutionary therapeutic technologies into one for a novel approach to treating cancer.
Siren Biotechnology, Inc. raised undisclosed on May 17, 2023
Investors: Founders Fund, ARTIS Ventures, Civilization Ventures, Lux Capital and Innovation Endeavors